secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2023-06-21T23:59:59+00:00
Accession:  0001493152-23-021934
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa CEO presents at MedInvest Oncology Investor Conference
---------------------------------------------------------------

- Dr. David Young presented on June 21, 2023 at 12:00 PM ET in Boston.
- Presentation titled 'Next Generation Chemotherapy to Improve Treatment of Cancer while Treating More Patients'.
- No specific financial or pipeline data disclosed; presentation posted on Processa's investor website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223021934/0001493152-23-021934-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223021934/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-021934

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer